D.A. Davidson & Co’s Pfizer PFE Stock Holding History

D.A. Davidson & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$89.4M	Buy	3,184,965 +90,012	+3%	+$2.4M	0.54%	38
2025 Q4	$77.1M	Sell	3,094,953 -43,723	-1%	-$1.1M	0.47%	43
2025 Q3	$80M	Buy	3,138,676 +70,161	+2%	+$1.73M	0.51%	40
2025 Q2	$74.4M	Buy	3,068,515 +1,130,014	+58%	+$26.4M	0.52%	38
2025 Q1	$49.1M	Buy	1,938,501 +179,060	+10%	+$4.69M	0.39%	51
2024 Q4	$46.7M	Sell	1,759,441 -45,258	-3%	-$1.23M	0.38%	46
2024 Q3	$52.2M	Buy	1,804,699 +233,609	+15%	+$6.81M	0.43%	46
2024 Q2	$44M	Buy	1,571,090 +408,234	+35%	+$11.2M	0.39%	49
2024 Q1	$32.3M	Buy	1,162,856 +508,108	+78%	+$14.1M	0.29%	62
2023 Q4	$18.9M	Sell	654,748 -82,381	-11%	-$2.49M	0.18%	95
2023 Q3	$24.5M	Buy	737,129 +22,777	+3%	+$805K	0.27%	71
2023 Q2	$26.2M	Buy	714,352 +40,015	+6%	+$1.56M	0.28%	69
2023 Q1	$27.5M	Sell	674,337 -61,971	-8%	-$2.68M	0.31%	64
2022 Q4	$37.7M	Buy	736,308 +13,632	+2%	+$654K	0.45%	49
2022 Q3	$31.6M	Buy	722,676 +16,867	+2%	+$820K	0.41%	54
2022 Q2	$37M	Buy	705,809 +19,426	+3%	+$990K	0.46%	47
2022 Q1	$35.5M	Buy	686,383 +10,712	+2%	+$556K	0.39%	54
2021 Q4	$39.9M	Buy	675,671 +2,700	+0.4%	+$134K	0.43%	49
2021 Q3	$28.9M	Buy	672,971 +4,501	+0.7%	+$199K	0.34%	60
2021 Q2	$26.2M	Buy	668,470 +14,693	+2%	+$571K	0.31%	67
2021 Q1	$23.7M	Buy	653,777 +182,725	+39%	+$6.49M	0.3%	70
2020 Q4	$17.3M	Buy	471,052 +15,082	+3%	+$553K	0.27%	73
2020 Q3	$15.9M	Buy	455,970 +60,963	+15%	+$2.14M	0.28%	67
2020 Q2	$12.3M	Sell	395,007 -94,150	-19%	-$3.2M	0.23%	79
2020 Q1	$15.1M	Buy	489,157 +35,627	+8%	+$1.21M	0.3%	66
2019 Q4	$16.9M	Buy	453,530 +50,012	+12%	+$1.78M	0.27%	74
2019 Q3	$13.8M	Buy	403,518 +17,388	+5%	+$632K	0.25%	77
2019 Q2	$15.9M	Sell	386,130 -41,358	-10%	-$1.64M	0.3%	61
2019 Q1	$17.3M	Sell	427,488 -4,699	-1%	-$188K	0.3%	61
2018 Q4	$17.9M	Buy	432,187 +7,698	+2%	+$320K	0.35%	56
2018 Q3	$17.7M	Sell	424,489 -10,145	-2%	-$391K	0.32%	57
2018 Q2	$15M	Buy	434,634 +4,110	+1%	+$140K	0.29%	62
2018 Q1	$14.5M	Buy	430,524 +6,121	+1%	+$210K	0.3%	62
2017 Q4	$14.6M	Buy	424,403 +15,196	+4%	+$518K	0.31%	61
2017 Q3	$13.9M	Buy	409,207 +6,412	+2%	+$206K	0.27%	77
2017 Q2	$12.8M	Buy	402,795 +16,763	+4%	+$529K	0.29%	65
2017 Q1	$12.5M	Sell	386,032 -377,088	-49%	-$11.9M	0.3%	65
2016 Q4	$23.5M	Buy	763,120 +25,908	+4%	+$791K	0.53%	39
2016 Q3	$23.7M	Buy	737,212 +91,941	+14%	+$3.07M	0.59%	35
2016 Q2	$21.6M	Buy	645,271 +14,166	+2%	+$452K	0.63%	28
2016 Q1	$17.7M	Buy	631,105 +72,741	+13%	+$2.08M	0.55%	36
2015 Q4	$17.1M	Buy	558,364 +4,285	+0.8%	+$135K	0.56%	33
2015 Q3	$16.5M	Sell	554,079 -7,489	-1%	-$240K	0.58%	31
2015 Q2	$17.9M	Buy	561,568 +15,629	+3%	+$509K	0.59%	31
2015 Q1	$18M	Sell	545,939 -50,883	-9%	-$1.62M	0.59%	32
2014 Q4	$17.6M	Buy	596,822 +5,684	+1%	+$163K	0.58%	37
2014 Q3	$16.6M	Sell	591,138 -2,607	-0.4%	-$73.2K	0.56%	37
2014 Q2	$16.7M	Buy	593,745 +50,641	+9%	+$1.44M	0.57%	37
2014 Q1	$16.5M	Sell	543,104 -23,375	-4%	-$697K	0.59%	36
2013 Q4	$16.5M	Buy	566,479 +63,456	+13%	+$1.85M	0.61%	32
2013 Q3	$13.7M	Buy	503,023 +181,779	+57%	+$4.95M	0.62%	30
2013 Q2	$8.53M	Buy	+321,244	New	+$8.88M	0.41%	52

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

D.A. Davidson & Co's PFE Position: Q1 2026 in Review

D.A. Davidson & Co increased its Pfizer (PFE) stake by 2.9% in Q1 2026, buying an estimated $2.4M and bringing the position to 3,184,965 shares worth $89.4M. The position accounts for 0.54% of the portfolio, ranked #38.

D.A. Davidson & Co first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

D.A. Davidson & Co held 3,184,965 shares of Pfizer worth $89.4M as of Q1 2026.
D.A. Davidson & Co bought 90,012 Pfizer shares in Q1 2026, an estimated $2.4M.
Pfizer made up 0.54% of D.A. Davidson & Co's portfolio in Q1 2026, its #38 holding.
D.A. Davidson & Co first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.